The biggest and most comprehensive analysis of GLP-1 receptor agonists on kidney and cardiovascular outcomes shows that they significantly benefit people with and without diabetes. …
Study finds popular diabetes and obesity drugs also protect kidneys
November 27, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Senate committee to question PBAC chair on submission deferrals
November 27, 2024 - - Latest News -
Study finds popular diabetes and obesity drugs also protect kidneys
November 27, 2024 - - Latest News -
Organon makes the move from Macquarie Park to Sydney's CBD
November 26, 2024 - - Latest News -
New report highlights the lack of research on climate change and health impacts
November 26, 2024 - - Latest News -
The comments were not as clear, but they clearly frame the implementation as a negotiation
November 26, 2024 - - Latest News -
GE HealthCare and Peter MacCallum Cancer Centre partner to advance cancer research
November 26, 2024 - - Latest News -
New research shows confidence-robbing condition impacts one-in-three men aged over 40
November 26, 2024 - - Latest News